Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05891288
Other study ID # Bioactive fissue sealant
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date July 1, 2023
Est. completion date August 1, 2024

Study information

Verified date May 2023
Source Cairo University
Contact Omar Shaalan
Phone 01122665661
Email omar.shaalan@dentistry.cu.edu.eg
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to compare the performance of newly introduced bioactive resin based pits and fissure sealant versus fluoride releasing resin based pits and fissure sealant in initial carious lesions of fissures in posterior molars in patients at risk of caries. Visual tactile examination and VistaCAM will be used for evaluation.


Description:

SmartCap™ Technology, which is used in the novel bioactive fissure sealant, is based on proprietary semi-permeable resin microcapsules. The rechargeable SmartCap microcapsules in BioCoat are packed with ionic fluoride, calcium, and phosphate solutions that diffuse in and out of the sealant. It is hypothesized that fluoride uptake is increased in the presence of calcium and phosphate ions. With little evidence-based information in the literature about using bioactive fissure sealants to seal initial carious lesions, it was determined that a randomized controlled trial would be beneficial in testing the null hypothesis that bioactive resin pits and fissure sealant will have the same clinical performance as fluoride releasing resin-based pits and fissure sealant in fissures with initial caries.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 36
Est. completion date August 1, 2024
Est. primary completion date July 1, 2024
Accepts healthy volunteers No
Gender All
Age group 19 Years to 30 Years
Eligibility Inclusion Criteria: - Patients with bilateral initial carious fissures in molars showing no signs of caries. - Co-operative patients approving to participate in the trial. Exclusion Criteria: - Sound fissures. - Pregnancy. - Disabilities. - Systemic disease or severe medical complications. - Rampant caries. - Heavy smoking. - Xerostomia. - Lack of compliance. - Evidence of severe bruxism, clenching, or tempromandibular joint disorders.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
BioCoat® by Premier®
Bioactive pits and fissure sealant
3M™ Clinpro™ Sealant.
Fluoride releasing pits and fissure sealant

Locations

Country Name City State
Egypt Faculty of Dentistry, Cairo University Cairo El Manial

Sponsors (1)

Lead Sponsor Collaborator
Cairo University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Retention of sealant rate of sealant loss 1 year
Secondary Caries incidence Rate of caries progression 1 year
See also
  Status Clinical Trial Phase
Not yet recruiting NCT04903275 - Caries Inhibition With CO2-Laser During Orthodontic Treatment N/A
Not yet recruiting NCT05094492 - Evaluation of Remineralization Potential of Self Assembling Peptide Combined With Fluoride N/A
Recruiting NCT05969756 - Early Treatments for Preventing Occlusal Caries Lesions N/A
Not yet recruiting NCT04929327 - Retention Rate of Self-etch Resin Based Sealant With and Without Prior Sandblasting N/A
Completed NCT05127356 - Diagnostic Accuracy of DIAGNOdent Compared to ICDAS II
Recruiting NCT04092296 - Efficacy of Resin Infiltration of Proximal Caries N/A